CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects antibody (including IgG and IgM) to SARS-CoV-2 S protein on April 20, 2020. Additionally, Vitalant Research Institute is offering the SARS-CoV-2 Reporter Viral Particle Neutralization (RVPN) test.
The situation is rapidly developing and we know you likely have many questions, but you can find all the current information here: Communications
We will be sending updates as we get more details to share with you!
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...